| 1 | them | 14,751 |
| 2 | him | 182 |
| 3 | him/her | 18 |
| 4 | seagrasses | 13 |
| 5 | pnls | 11 |
| 6 | embryologists | 9 |
| 7 | cattails | 8 |
| 8 | sylvius | 8 |
| 9 | 2-ketobutyrate | 7 |
| 10 | aoxyn11a | 7 |
| 11 | drones | 7 |
| 12 | tecp | 7 |
| 13 | 3-diazooxindoles | 6 |
| 14 | bpvs | 6 |
| 15 | fistulas-in-ano | 6 |
| 16 | re-presentation | 6 |
| 17 | salamanders | 6 |
| 18 | bedpans | 5 |
| 19 | bioplastics | 5 |
| 20 | clinician-scientists | 5 |
| 21 | cserps | 5 |
| 22 | pemt-pc | 5 |
| 23 | post-fdacm | 5 |
| 24 | resmethrin | 5 |
| 25 | rictor | 5 |
| 26 | 8-thioguanosine | 4 |
| 27 | allenoates | 4 |
| 28 | bcl10 | 4 |
| 29 | dilatrend | 4 |
| 30 | homoeriodictyol | 4 |
| 31 | moaa | 4 |
| 32 | non-adolescents | 4 |
| 33 | non-beta-lactams | 4 |
| 34 | phbhhx/pcl | 4 |
| 35 | rix4414/placebo | 4 |
| 36 | rs12691 | 4 |
| 37 | self-stigmatization | 4 |
| 38 | tso-yueh-tzu | 4 |
| 39 | wettings | 4 |
| 40 | 10g/kg | 3 |
| 41 | 5451 | 3 |
| 42 | ability/desire/need | 3 |
| 43 | andropenia | 3 |
| 44 | bromophenols | 3 |
| 45 | cheesecloth | 3 |
| 46 | cys267 | 3 |
| 47 | dibucaine | 3 |
| 48 | emmetropization | 3 |
| 49 | errors/problems | 3 |
| 50 | fa'asamoa | 3 |
| 51 | fhcd59-1.1 | 3 |
| 52 | flavorase | 3 |
| 53 | ifn-alpha/il-2 | 3 |
| 54 | individuals/families | 3 |
| 55 | isoreceptors | 3 |
| 56 | l857 | 3 |
| 57 | matriculants | 3 |
| 58 | multi-pharmacy | 3 |
| 59 | non-bingers | 3 |
| 60 | ontd/vwd | 3 |
| 61 | pediatric-gastroenterology | 3 |
| 62 | sipvs | 3 |
| 63 | topsoils | 3 |
| 64 | truck-drivers | 3 |
| 65 | uro-pathogens | 3 |
| 66 | 1,3-β-dglucan | 2 |
| 67 | 10,520 | 2 |
| 68 | 10-20mmhg | 2 |
| 69 | 18-49-year-olds | 2 |
| 70 | 2',3',5'-tri-o-acyluridines | 2 |
| 71 | 2-aminopyrimidines | 2 |
| 72 | 2-hydroxy-3,4,6-trimethoxyacetophenone | 2 |
| 73 | 2-substituted-3-sulfonylaminobenzamide | 2 |
| 74 | 3'-indolyl-3-oxindole | 2 |
| 75 | 3,6-dioxa-1,8-octanedithiol | 2 |
| 76 | 3-cyclopentenol | 2 |
| 77 | 3-en-1-ynes | 2 |
| 78 | 3-formylfurans | 2 |
| 79 | 3h-glycerol | 2 |
| 80 | 4-6months | 2 |
| 81 | 5-17-year-olds | 2 |
| 82 | 5-fu/fa/cpt11 | 2 |
| 83 | 8-ohdpat | 2 |
| 84 | a.h.c.p.r | 2 |
| 85 | adult-asthmatics | 2 |
| 86 | afl/at | 2 |
| 87 | aflfff-malls | 2 |
| 88 | age-eligibles | 2 |
| 89 | anti-lts | 2 |
| 90 | archaeol | 2 |
| 91 | aryllithiums | 2 |
| 92 | backbonding | 2 |
| 93 | bio-detection | 2 |
| 94 | cambrella | 2 |
| 95 | chelants | 2 |
| 96 | chimaltenango | 2 |
| 97 | cis-cyclooctene | 2 |
| 98 | cm-pd | 2 |
| 99 | copepodamides | 2 |
| 100 | craiova | 2 |
| 101 | cys263 | 2 |
| 102 | dcj/day | 2 |
| 103 | dermocosmetics | 2 |
| 104 | dypnones | 2 |
| 105 | evidence-gathering | 2 |
| 106 | galantamine/cdp-choline | 2 |
| 107 | ginsenoside-m1 | 2 |
| 108 | gondwana | 2 |
| 109 | granulomorphometry | 2 |
| 110 | inotropes/vasopressors | 2 |
| 111 | integrationists | 2 |
| 112 | ips/se | 2 |
| 113 | irkv-thchina12 | 2 |
| 114 | laminarioligosaccharides | 2 |
| 115 | letrozole/temsirolimus | 2 |
| 116 | lodgment | 2 |
| 117 | mascara | 2 |
| 118 | met-trnaf | 2 |
| 119 | metallopolymer | 2 |
| 120 | neuroblockade | 2 |
| 121 | noncontacts | 2 |
| 122 | nsabp-b32 | 2 |
| 123 | perimyocarditis | 2 |
| 124 | photogermination | 2 |
| 125 | photothera | 2 |
| 126 | preoligodendrocytes | 2 |
| 127 | preterm-aga | 2 |
| 128 | prometra-uganda | 2 |
| 129 | promutagens | 2 |
| 130 | psaty | 2 |
| 131 | psycho-existential | 2 |
| 132 | radio-content | 2 |
| 133 | self-isolation | 2 |
| 134 | self-persuasion | 2 |
| 135 | sski | 2 |
| 136 | sub-task | 2 |
| 137 | target-organs | 2 |
| 138 | taural | 2 |
| 139 | thiocolchicine | 2 |
| 140 | thp-1cells | 2 |
| 141 | underclothing | 2 |
| 142 | video-consultation | 2 |
| 143 | videotelephony | 2 |
| 144 | vph | 2 |
| 145 | windhoek | 2 |
| 146 | överkalix | 2 |
| 147 | αs2-casein | 2 |
| 148 | €4451 | 2 |
| 149 | ≤0.13 | 2 |
| 150 | 'face | 1 |
| 151 | 'preaching | 1 |
| 152 | 'starving | 1 |
| 153 | -0.542 | 1 |
| 154 | -13.05 | 1 |
| 155 | -2.402 | 1 |
| 156 | -30.9° | 1 |
| 157 | -757 | 1 |
| 158 | -€4476 | 1 |
| 159 | 0.5/0.6 | 1 |
| 160 | 0.9277 | 1 |
| 161 | 0.9624 | 1 |
| 162 | 01/07/2011 | 1 |
| 163 | 04/11/2010 | 1 |
| 164 | 1,3,7,8-tcdd | 1 |
| 165 | 1.2693 | 1 |
| 166 | 1.8. | 1 |
| 167 | 1/1/2006-12/31/2010 | 1 |
| 168 | 100°c/s | 1 |
| 169 | 1083d | 1 |
| 170 | 111°c | 1 |
| 171 | 11α-hydroxy | 1 |
| 172 | 13,420 | 1 |
| 173 | 15,466 | 1 |
| 174 | 161.2μv | 1 |
| 175 | 16±2 | 1 |
| 176 | 18,593 | 1 |
| 177 | 182/110 | 1 |
| 178 | 1986/87 | 1 |
| 179 | 1:150 | 1 |
| 180 | 2'7'-dichlorofluorescin | 1 |
| 181 | 2,3-monoepoxysqualene | 1 |
| 182 | 21,935 | 1 |
| 183 | 22.3±6.3 | 1 |
| 184 | 23.3±7.3 | 1 |
| 185 | 23.77±1.37 | 1 |
| 186 | 23.7±5.7 | 1 |
| 187 | 24-atoms | 1 |
| 188 | 251.55 | 1 |
| 189 | 26,104 | 1 |
| 190 | 27.37±2.73 | 1 |
| 191 | 27°-30° | 1 |
| 192 | 2:1:1:1:2 | 1 |
| 193 | 2mg/week | 1 |
| 194 | 3,244 | 1 |
| 195 | 3,3-diethoxypropyne | 1 |
| 196 | 3,41 | 1 |
| 197 | 3,5,3',4'-tetrahydroxy-trans-stilbene | 1 |
| 198 | 3-fluoro-2-methyldecanoyl-coas | 1 |
| 199 | 3-methylcarbazole | 1 |
| 200 | 3.80°c | 1 |
| 201 | 33p-2mes-adp | 1 |
| 202 | 340+/-57 | 1 |
| 203 | 4,398 | 1 |
| 204 | 4-hydroxymandelate | 1 |
| 205 | 4-pentyn-1-amine | 1 |
| 206 | 410-495nm | 1 |
| 207 | 424,526 | 1 |
| 208 | 5-14-year-olds | 1 |
| 209 | 50119 | 1 |
| 210 | 527.00 | 1 |
| 211 | 54min | 1 |
| 212 | 5871 | 1 |
| 213 | 60-69-year-olds | 1 |
| 214 | 60-ns | 1 |
| 215 | 63±11mmol/mol | 1 |
| 216 | 68.12±1.27 | 1 |
| 217 | 6yrs | 1 |
| 218 | 7.11±0.04 | 1 |
| 219 | 7.37°c | 1 |
| 220 | 7:7:4:4 | 1 |
| 221 | 80.6±22.7 | 1 |
| 222 | 8477 | 1 |
| 223 | 85,806 | 1 |
| 224 | 9a-p | 1 |
| 225 | ace/ras | 1 |
| 226 | adrenocorticoids | 1 |
| 227 | ages-hsa | 1 |
| 228 | aggregans | 1 |
| 229 | alkyl-tricarbastannatranes | 1 |
| 230 | allyloxybenzene | 1 |
| 231 | aminoazoles | 1 |
| 232 | anaemiarelated | 1 |
| 233 | andantiandrogen | 1 |
| 234 | anp-gc | 1 |
| 235 | antibioticotherapy | 1 |
| 236 | anticomedogenic | 1 |
| 237 | antisocials | 1 |
| 238 | arg904 | 1 |
| 239 | aris.objectives | 1 |
| 240 | aromatherapies | 1 |
| 241 | arterioscleroses | 1 |
| 242 | ask1leads | 1 |
| 243 | baseline-dependence | 1 |
| 244 | basion | 1 |
| 245 | beach-goers | 1 |
| 246 | bevacuzimab | 1 |
| 247 | biharwe | 1 |
| 248 | binding/release | 1 |
| 249 | biohybrids | 1 |
| 250 | biosimilar-infliximab | 1 |
| 251 | bmscs/control | 1 |
| 252 | brevipalpis | 1 |
| 253 | bromo-amination | 1 |
| 254 | c3-7α-fes | 1 |
| 255 | caif/iaif | 1 |
| 256 | cascadeflo | 1 |
| 257 | cd208 | 1 |
| 258 | cell1/2 | 1 |
| 259 | cell17 | 1 |
| 260 | change/readiness | 1 |
| 261 | cjph | 1 |
| 262 | cncc | 1 |
| 263 | cni-reduction | 1 |
| 264 | co-medicals | 1 |
| 265 | combinedexposure | 1 |
| 266 | conspiring | 1 |
| 267 | controls/designs/patients | 1 |
| 268 | cooperaration | 1 |
| 269 | cpod | 1 |
| 270 | cross-examination-given | 1 |
| 271 | cs-s1-s2 | 1 |
| 272 | csf/leukoaraiosis | 1 |
| 273 | dc-therapy | 1 |
| 274 | decursin/da | 1 |
| 275 | demulcents | 1 |
| 276 | dfe/dncb | 1 |
| 277 | diphtheria/pertussis/typhoid | 1 |
| 278 | disease-phenotype-gene-drug | 1 |
| 279 | ebb/tblb | 1 |
| 280 | elastoviscosity | 1 |
| 281 | endotoxinin | 1 |
| 282 | epros | 1 |
| 283 | erythrocytes.we | 1 |
| 284 | eu2o3 | 1 |
| 285 | eubiotics | 1 |
| 286 | eumetazoans | 1 |
| 287 | euro30,350 | 1 |
| 288 | european/american | 1 |
| 289 | evidence-based-practice | 1 |
| 290 | face-washing | 1 |
| 291 | fondaparinucs | 1 |
| 292 | fuel-n | 1 |
| 293 | g-mdsc | 1 |
| 294 | gamebikes | 1 |
| 295 | ganitumab-a | 1 |
| 296 | gbs.moderate | 1 |
| 297 | gdp-rac1 | 1 |
| 298 | glu295 | 1 |
| 299 | glycosyloxadiazolinethiones | 1 |
| 300 | god-given | 1 |
| 301 | gold-etched | 1 |
| 302 | gold-sputtered | 1 |
| 303 | governments/policymakers | 1 |
| 304 | half-faces | 1 |
| 305 | hemorrhagy | 1 |
| 306 | high-reynolds-number | 1 |
| 307 | hongdan | 1 |
| 308 | htpr+ | 1 |
| 309 | hypercompetition | 1 |
| 310 | idio-fluorochrome | 1 |
| 311 | immunity/infection | 1 |
| 312 | indo-trinidadians | 1 |
| 313 | inhibitor/activator | 1 |
| 314 | intellectual- | 1 |
| 315 | intermediate-to-low-dose | 1 |
| 316 | isoamyl-3-oxobutanoate | 1 |
| 317 | itask-1 | 1 |
| 318 | k364 | 1 |
| 319 | lacan | 1 |
| 320 | laropiprant+digoxin | 1 |
| 321 | lectureship | 1 |
| 322 | leukaemia-induced | 1 |
| 323 | life.five | 1 |
| 324 | lithostatically | 1 |
| 325 | lithuanians | 1 |
| 326 | ln-mofs | 1 |
| 327 | loe-4 | 1 |
| 328 | lupus.according | 1 |
| 329 | m1-receptors | 1 |
| 330 | meso-epoxides | 1 |
| 331 | met-trna | 1 |
| 332 | metformin+liraglutide | 1 |
| 333 | methylaliphatogenes | 1 |
| 334 | metronidazole-clotrimazole | 1 |
| 335 | mhc-beta | 1 |
| 336 | microalgea | 1 |
| 337 | microdecisions | 1 |
| 338 | micropremies | 1 |
| 339 | mini-helixes | 1 |
| 340 | missorting | 1 |
| 341 | monophenol | 1 |
| 342 | multi-algorithms | 1 |
| 343 | mutagencity | 1 |
| 344 | n-albumin | 1 |
| 345 | n-alkenylnitrones | 1 |
| 346 | n-hydroxyaminopropenes | 1 |
| 347 | na-and | 1 |
| 348 | nbd-ceramide | 1 |
| 349 | nct01122836 | 1 |
| 350 | nectins-1 | 1 |
| 351 | nephrohydrosis | 1 |
| 352 | nfs=0 | 1 |
| 353 | nmolar | 1 |
| 354 | non-immunes | 1 |
| 355 | nonabdes | 1 |
| 356 | norborene | 1 |
| 357 | nucleoplasmin | 1 |
| 358 | o-ethynylanisoles | 1 |
| 359 | octyl-2-cyanoacrylate | 1 |
| 360 | olympians | 1 |
| 361 | operatingmodes | 1 |
| 362 | ourense | 1 |
| 363 | oyashio | 1 |
| 364 | paclitaxel/cisplatin/gemcitabine | 1 |
| 365 | par-3/bazooka | 1 |
| 366 | paraultunense | 1 |
| 367 | parnuts | 1 |
| 368 | pcdna4.0 | 1 |
| 369 | peptidyl-arginine | 1 |
| 370 | phanerogam | 1 |
| 371 | phcn7 | 1 |
| 372 | phe114 | 1 |
| 373 | phe28 | 1 |
| 374 | phe41 | 1 |
| 375 | phosphatidylinositol-4,5-diphosphate | 1 |
| 376 | photo-oxidative-stress | 1 |
| 377 | physician-learners | 1 |
| 378 | phytane | 1 |
| 379 | piero | 1 |
| 380 | pnd7-13 | 1 |
| 381 | pnu-173575 | 1 |
| 382 | polybromoarenes | 1 |
| 383 | polyhydroxyalkanaotes | 1 |
| 384 | polysulfoanions | 1 |
| 385 | post-irrigation | 1 |
| 386 | posthyperemic | 1 |
| 387 | powered-toothbrushes | 1 |
| 388 | predentin | 1 |
| 389 | prehnite-pumpellyite | 1 |
| 390 | prospectically | 1 |
| 391 | pyrrole-3-carboxaldehydes | 1 |
| 392 | r-ma-d3 | 1 |
| 393 | radioiodine-131 | 1 |
| 394 | rdds | 1 |
| 395 | readmissions/admissions | 1 |
| 396 | referrals/linkages | 1 |
| 397 | rehab-patients | 1 |
| 398 | rescrubbing | 1 |
| 399 | resource-defined | 1 |
| 400 | results.studies | 1 |
| 401 | reverence | 1 |
| 402 | ricin-neutralizing | 1 |
| 403 | routine-eus-fna | 1 |
| 404 | rr-lf | 1 |
| 405 | saccharomycotina | 1 |
| 406 | selenoglycosides | 1 |
| 407 | septum-to-free-wall | 1 |
| 408 | ser72 | 1 |
| 409 | sert-r152e/e615k | 1 |
| 410 | sicklers | 1 |
| 411 | side-holes | 1 |
| 412 | sitagliplin | 1 |
| 413 | skill- | 1 |
| 414 | solutions-but | 1 |
| 415 | speen-qi | 1 |
| 416 | stage-wise | 1 |
| 417 | stockings/socks | 1 |
| 418 | st£253.38 | 1 |
| 419 | subnano- | 1 |
| 420 | suwon11 | 1 |
| 421 | t1/t0 | 1 |
| 422 | them.however | 1 |
| 423 | thermodamage | 1 |
| 424 | ticl4/et3sih | 1 |
| 425 | tisis/icp-ms | 1 |
| 426 | tothe.control | 1 |
| 427 | tourniquet-assisted | 1 |
| 428 | trans-3-haloacrylates | 1 |
| 429 | transquilization | 1 |
| 430 | treatment.objectives | 1 |
| 431 | trijodthyronine | 1 |
| 432 | trustee | 1 |
| 433 | tsse | 1 |
| 434 | uni/bimanual | 1 |
| 435 | us-results | 1 |
| 436 | vfrs.to | 1 |
| 437 | vibration/oscillation | 1 |
| 438 | video-instruction | 1 |
| 439 | wats | 1 |
| 440 | weaners | 1 |
| 441 | xantinuria | 1 |
| 442 | ypt1 | 1 |
| 443 | ypt2 | 1 |
| 444 | ~57 | 1 |
| 445 | £1887 | 1 |
| 446 | £8033 | 1 |
| 447 | β-d-psicofuranose | 1 |
| 448 | β-oac | 1 |
| 449 | ≈350- | 1 |
| 450 | ≤1:4 | 1 |
| 451 | ≥2000g | 1 |
| 1 | 'face | 1 |
| 2 | 'preaching | 1 |
| 3 | 'starving | 1 |
| 4 | -0.542 | 1 |
| 5 | -13.05 | 1 |
| 6 | -2.402 | 1 |
| 7 | -30.9° | 1 |
| 8 | -757 | 1 |
| 9 | -€4476 | 1 |
| 10 | 0.5/0.6 | 1 |
| 11 | 0.9277 | 1 |
| 12 | 0.9624 | 1 |
| 13 | 01/07/2011 | 1 |
| 14 | 04/11/2010 | 1 |
| 15 | 1,3,7,8-tcdd | 1 |
| 16 | 1,3-β-dglucan | 2 |
| 17 | 1.2693 | 1 |
| 18 | 1.8. | 1 |
| 19 | 1/1/2006-12/31/2010 | 1 |
| 20 | 10,520 | 2 |
| 21 | 10-20mmhg | 2 |
| 22 | 100°c/s | 1 |
| 23 | 1083d | 1 |
| 24 | 10g/kg | 3 |
| 25 | 111°c | 1 |
| 26 | 11α-hydroxy | 1 |
| 27 | 13,420 | 1 |
| 28 | 15,466 | 1 |
| 29 | 161.2μv | 1 |
| 30 | 16±2 | 1 |
| 31 | 18,593 | 1 |
| 32 | 18-49-year-olds | 2 |
| 33 | 182/110 | 1 |
| 34 | 1986/87 | 1 |
| 35 | 1:150 | 1 |
| 36 | 2',3',5'-tri-o-acyluridines | 2 |
| 37 | 2'7'-dichlorofluorescin | 1 |
| 38 | 2,3-monoepoxysqualene | 1 |
| 39 | 2-aminopyrimidines | 2 |
| 40 | 2-hydroxy-3,4,6-trimethoxyacetophenone | 2 |
| 41 | 2-ketobutyrate | 7 |
| 42 | 2-substituted-3-sulfonylaminobenzamide | 2 |
| 43 | 21,935 | 1 |
| 44 | 22.3±6.3 | 1 |
| 45 | 23.3±7.3 | 1 |
| 46 | 23.77±1.37 | 1 |
| 47 | 23.7±5.7 | 1 |
| 48 | 24-atoms | 1 |
| 49 | 251.55 | 1 |
| 50 | 26,104 | 1 |
| 51 | 27.37±2.73 | 1 |
| 52 | 27°-30° | 1 |
| 53 | 2:1:1:1:2 | 1 |
| 54 | 2mg/week | 1 |
| 55 | 3'-indolyl-3-oxindole | 2 |
| 56 | 3,244 | 1 |
| 57 | 3,3-diethoxypropyne | 1 |
| 58 | 3,41 | 1 |
| 59 | 3,5,3',4'-tetrahydroxy-trans-stilbene | 1 |
| 60 | 3,6-dioxa-1,8-octanedithiol | 2 |
| 61 | 3-cyclopentenol | 2 |
| 62 | 3-diazooxindoles | 6 |
| 63 | 3-en-1-ynes | 2 |
| 64 | 3-fluoro-2-methyldecanoyl-coas | 1 |
| 65 | 3-formylfurans | 2 |
| 66 | 3-methylcarbazole | 1 |
| 67 | 3.80°c | 1 |
| 68 | 33p-2mes-adp | 1 |
| 69 | 340+/-57 | 1 |
| 70 | 3h-glycerol | 2 |
| 71 | 4,398 | 1 |
| 72 | 4-6months | 2 |
| 73 | 4-hydroxymandelate | 1 |
| 74 | 4-pentyn-1-amine | 1 |
| 75 | 410-495nm | 1 |
| 76 | 424,526 | 1 |
| 77 | 5-14-year-olds | 1 |
| 78 | 5-17-year-olds | 2 |
| 79 | 5-fu/fa/cpt11 | 2 |
| 80 | 50119 | 1 |
| 81 | 527.00 | 1 |
| 82 | 5451 | 3 |
| 83 | 54min | 1 |
| 84 | 5871 | 1 |
| 85 | 60-69-year-olds | 1 |
| 86 | 60-ns | 1 |
| 87 | 63±11mmol/mol | 1 |
| 88 | 68.12±1.27 | 1 |
| 89 | 6yrs | 1 |
| 90 | 7.11±0.04 | 1 |
| 91 | 7.37°c | 1 |
| 92 | 7:7:4:4 | 1 |
| 93 | 8-ohdpat | 2 |
| 94 | 8-thioguanosine | 4 |
| 95 | 80.6±22.7 | 1 |
| 96 | 8477 | 1 |
| 97 | 85,806 | 1 |
| 98 | 9a-p | 1 |
| 99 | a.h.c.p.r | 2 |
| 100 | ability/desire/need | 3 |
| 101 | ace/ras | 1 |
| 102 | adrenocorticoids | 1 |
| 103 | adult-asthmatics | 2 |
| 104 | afl/at | 2 |
| 105 | aflfff-malls | 2 |
| 106 | age-eligibles | 2 |
| 107 | ages-hsa | 1 |
| 108 | aggregans | 1 |
| 109 | alkyl-tricarbastannatranes | 1 |
| 110 | allenoates | 4 |
| 111 | allyloxybenzene | 1 |
| 112 | aminoazoles | 1 |
| 113 | anaemiarelated | 1 |
| 114 | andantiandrogen | 1 |
| 115 | andropenia | 3 |
| 116 | anp-gc | 1 |
| 117 | anti-lts | 2 |
| 118 | antibioticotherapy | 1 |
| 119 | anticomedogenic | 1 |
| 120 | antisocials | 1 |
| 121 | aoxyn11a | 7 |
| 122 | archaeol | 2 |
| 123 | arg904 | 1 |
| 124 | aris.objectives | 1 |
| 125 | aromatherapies | 1 |
| 126 | arterioscleroses | 1 |
| 127 | aryllithiums | 2 |
| 128 | ask1leads | 1 |
| 129 | backbonding | 2 |
| 130 | baseline-dependence | 1 |
| 131 | basion | 1 |
| 132 | bcl10 | 4 |
| 133 | beach-goers | 1 |
| 134 | bedpans | 5 |
| 135 | bevacuzimab | 1 |
| 136 | biharwe | 1 |
| 137 | binding/release | 1 |
| 138 | bio-detection | 2 |
| 139 | biohybrids | 1 |
| 140 | bioplastics | 5 |
| 141 | biosimilar-infliximab | 1 |
| 142 | bmscs/control | 1 |
| 143 | bpvs | 6 |
| 144 | brevipalpis | 1 |
| 145 | bromo-amination | 1 |
| 146 | bromophenols | 3 |
| 147 | c3-7α-fes | 1 |
| 148 | caif/iaif | 1 |
| 149 | cambrella | 2 |
| 150 | cascadeflo | 1 |
| 151 | cattails | 8 |
| 152 | cd208 | 1 |
| 153 | cell1/2 | 1 |
| 154 | cell17 | 1 |
| 155 | change/readiness | 1 |
| 156 | cheesecloth | 3 |
| 157 | chelants | 2 |
| 158 | chimaltenango | 2 |
| 159 | cis-cyclooctene | 2 |
| 160 | cjph | 1 |
| 161 | clinician-scientists | 5 |
| 162 | cm-pd | 2 |
| 163 | cncc | 1 |
| 164 | cni-reduction | 1 |
| 165 | co-medicals | 1 |
| 166 | combinedexposure | 1 |
| 167 | conspiring | 1 |
| 168 | controls/designs/patients | 1 |
| 169 | cooperaration | 1 |
| 170 | copepodamides | 2 |
| 171 | cpod | 1 |
| 172 | craiova | 2 |
| 173 | cross-examination-given | 1 |
| 174 | cs-s1-s2 | 1 |
| 175 | cserps | 5 |
| 176 | csf/leukoaraiosis | 1 |
| 177 | cys263 | 2 |
| 178 | cys267 | 3 |
| 179 | dc-therapy | 1 |
| 180 | dcj/day | 2 |
| 181 | decursin/da | 1 |
| 182 | demulcents | 1 |
| 183 | dermocosmetics | 2 |
| 184 | dfe/dncb | 1 |
| 185 | dibucaine | 3 |
| 186 | dilatrend | 4 |
| 187 | diphtheria/pertussis/typhoid | 1 |
| 188 | disease-phenotype-gene-drug | 1 |
| 189 | drones | 7 |
| 190 | dypnones | 2 |
| 191 | ebb/tblb | 1 |
| 192 | elastoviscosity | 1 |
| 193 | embryologists | 9 |
| 194 | emmetropization | 3 |
| 195 | endotoxinin | 1 |
| 196 | epros | 1 |
| 197 | errors/problems | 3 |
| 198 | erythrocytes.we | 1 |
| 199 | eu2o3 | 1 |
| 200 | eubiotics | 1 |
| 201 | eumetazoans | 1 |
| 202 | euro30,350 | 1 |
| 203 | european/american | 1 |
| 204 | evidence-based-practice | 1 |
| 205 | evidence-gathering | 2 |
| 206 | fa'asamoa | 3 |
| 207 | face-washing | 1 |
| 208 | fhcd59-1.1 | 3 |
| 209 | fistulas-in-ano | 6 |
| 210 | flavorase | 3 |
| 211 | fondaparinucs | 1 |
| 212 | fuel-n | 1 |
| 213 | g-mdsc | 1 |
| 214 | galantamine/cdp-choline | 2 |
| 215 | gamebikes | 1 |
| 216 | ganitumab-a | 1 |
| 217 | gbs.moderate | 1 |
| 218 | gdp-rac1 | 1 |
| 219 | ginsenoside-m1 | 2 |
| 220 | glu295 | 1 |
| 221 | glycosyloxadiazolinethiones | 1 |
| 222 | god-given | 1 |
| 223 | gold-etched | 1 |
| 224 | gold-sputtered | 1 |
| 225 | gondwana | 2 |
| 226 | governments/policymakers | 1 |
| 227 | granulomorphometry | 2 |
| 228 | half-faces | 1 |
| 229 | hemorrhagy | 1 |
| 230 | high-reynolds-number | 1 |
| 231 | him | 182 |
| 232 | him/her | 18 |
| 233 | homoeriodictyol | 4 |
| 234 | hongdan | 1 |
| 235 | htpr+ | 1 |
| 236 | hypercompetition | 1 |
| 237 | idio-fluorochrome | 1 |
| 238 | ifn-alpha/il-2 | 3 |
| 239 | immunity/infection | 1 |
| 240 | individuals/families | 3 |
| 241 | indo-trinidadians | 1 |
| 242 | inhibitor/activator | 1 |
| 243 | inotropes/vasopressors | 2 |
| 244 | integrationists | 2 |
| 245 | intellectual- | 1 |
| 246 | intermediate-to-low-dose | 1 |
| 247 | ips/se | 2 |
| 248 | irkv-thchina12 | 2 |
| 249 | isoamyl-3-oxobutanoate | 1 |
| 250 | isoreceptors | 3 |
| 251 | itask-1 | 1 |
| 252 | k364 | 1 |
| 253 | l857 | 3 |
| 254 | lacan | 1 |
| 255 | laminarioligosaccharides | 2 |
| 256 | laropiprant+digoxin | 1 |
| 257 | lectureship | 1 |
| 258 | letrozole/temsirolimus | 2 |
| 259 | leukaemia-induced | 1 |
| 260 | life.five | 1 |
| 261 | lithostatically | 1 |
| 262 | lithuanians | 1 |
| 263 | ln-mofs | 1 |
| 264 | lodgment | 2 |
| 265 | loe-4 | 1 |
| 266 | lupus.according | 1 |
| 267 | m1-receptors | 1 |
| 268 | mascara | 2 |
| 269 | matriculants | 3 |
| 270 | meso-epoxides | 1 |
| 271 | met-trna | 1 |
| 272 | met-trnaf | 2 |
| 273 | metallopolymer | 2 |
| 274 | metformin+liraglutide | 1 |
| 275 | methylaliphatogenes | 1 |
| 276 | metronidazole-clotrimazole | 1 |
| 277 | mhc-beta | 1 |
| 278 | microalgea | 1 |
| 279 | microdecisions | 1 |
| 280 | micropremies | 1 |
| 281 | mini-helixes | 1 |
| 282 | missorting | 1 |
| 283 | moaa | 4 |
| 284 | monophenol | 1 |
| 285 | multi-algorithms | 1 |
| 286 | multi-pharmacy | 3 |
| 287 | mutagencity | 1 |
| 288 | n-albumin | 1 |
| 289 | n-alkenylnitrones | 1 |
| 290 | n-hydroxyaminopropenes | 1 |
| 291 | na-and | 1 |
| 292 | nbd-ceramide | 1 |
| 293 | nct01122836 | 1 |
| 294 | nectins-1 | 1 |
| 295 | nephrohydrosis | 1 |
| 296 | neuroblockade | 2 |
| 297 | nfs=0 | 1 |
| 298 | nmolar | 1 |
| 299 | non-adolescents | 4 |
| 300 | non-beta-lactams | 4 |
| 301 | non-bingers | 3 |
| 302 | non-immunes | 1 |
| 303 | nonabdes | 1 |
| 304 | noncontacts | 2 |
| 305 | norborene | 1 |
| 306 | nsabp-b32 | 2 |
| 307 | nucleoplasmin | 1 |
| 308 | o-ethynylanisoles | 1 |
| 309 | octyl-2-cyanoacrylate | 1 |
| 310 | olympians | 1 |
| 311 | ontd/vwd | 3 |
| 312 | operatingmodes | 1 |
| 313 | ourense | 1 |
| 314 | oyashio | 1 |
| 315 | paclitaxel/cisplatin/gemcitabine | 1 |
| 316 | par-3/bazooka | 1 |
| 317 | paraultunense | 1 |
| 318 | parnuts | 1 |
| 319 | pcdna4.0 | 1 |
| 320 | pediatric-gastroenterology | 3 |
| 321 | pemt-pc | 5 |
| 322 | peptidyl-arginine | 1 |
| 323 | perimyocarditis | 2 |
| 324 | phanerogam | 1 |
| 325 | phbhhx/pcl | 4 |
| 326 | phcn7 | 1 |
| 327 | phe114 | 1 |
| 328 | phe28 | 1 |
| 329 | phe41 | 1 |
| 330 | phosphatidylinositol-4,5-diphosphate | 1 |
| 331 | photo-oxidative-stress | 1 |
| 332 | photogermination | 2 |
| 333 | photothera | 2 |
| 334 | physician-learners | 1 |
| 335 | phytane | 1 |
| 336 | piero | 1 |
| 337 | pnd7-13 | 1 |
| 338 | pnls | 11 |
| 339 | pnu-173575 | 1 |
| 340 | polybromoarenes | 1 |
| 341 | polyhydroxyalkanaotes | 1 |
| 342 | polysulfoanions | 1 |
| 343 | post-fdacm | 5 |
| 344 | post-irrigation | 1 |
| 345 | posthyperemic | 1 |
| 346 | powered-toothbrushes | 1 |
| 347 | predentin | 1 |
| 348 | prehnite-pumpellyite | 1 |
| 349 | preoligodendrocytes | 2 |
| 350 | preterm-aga | 2 |
| 351 | prometra-uganda | 2 |
| 352 | promutagens | 2 |
| 353 | prospectically | 1 |
| 354 | psaty | 2 |
| 355 | psycho-existential | 2 |
| 356 | pyrrole-3-carboxaldehydes | 1 |
| 357 | r-ma-d3 | 1 |
| 358 | radio-content | 2 |
| 359 | radioiodine-131 | 1 |
| 360 | rdds | 1 |
| 361 | re-presentation | 6 |
| 362 | readmissions/admissions | 1 |
| 363 | referrals/linkages | 1 |
| 364 | rehab-patients | 1 |
| 365 | rescrubbing | 1 |
| 366 | resmethrin | 5 |
| 367 | resource-defined | 1 |
| 368 | results.studies | 1 |
| 369 | reverence | 1 |
| 370 | ricin-neutralizing | 1 |
| 371 | rictor | 5 |
| 372 | rix4414/placebo | 4 |
| 373 | routine-eus-fna | 1 |
| 374 | rr-lf | 1 |
| 375 | rs12691 | 4 |
| 376 | saccharomycotina | 1 |
| 377 | salamanders | 6 |
| 378 | seagrasses | 13 |
| 379 | selenoglycosides | 1 |
| 380 | self-isolation | 2 |
| 381 | self-persuasion | 2 |
| 382 | self-stigmatization | 4 |
| 383 | septum-to-free-wall | 1 |
| 384 | ser72 | 1 |
| 385 | sert-r152e/e615k | 1 |
| 386 | sicklers | 1 |
| 387 | side-holes | 1 |
| 388 | sipvs | 3 |
| 389 | sitagliplin | 1 |
| 390 | skill- | 1 |
| 391 | solutions-but | 1 |
| 392 | speen-qi | 1 |
| 393 | sski | 2 |
| 394 | stage-wise | 1 |
| 395 | stockings/socks | 1 |
| 396 | st£253.38 | 1 |
| 397 | sub-task | 2 |
| 398 | subnano- | 1 |
| 399 | suwon11 | 1 |
| 400 | sylvius | 8 |
| 401 | t1/t0 | 1 |
| 402 | target-organs | 2 |
| 403 | taural | 2 |
| 404 | tecp | 7 |
| 405 | them | 14,751 |
| 406 | them.however | 1 |
| 407 | thermodamage | 1 |
| 408 | thiocolchicine | 2 |
| 409 | thp-1cells | 2 |
| 410 | ticl4/et3sih | 1 |
| 411 | tisis/icp-ms | 1 |
| 412 | topsoils | 3 |
| 413 | tothe.control | 1 |
| 414 | tourniquet-assisted | 1 |
| 415 | trans-3-haloacrylates | 1 |
| 416 | transquilization | 1 |
| 417 | treatment.objectives | 1 |
| 418 | trijodthyronine | 1 |
| 419 | truck-drivers | 3 |
| 420 | trustee | 1 |
| 421 | tso-yueh-tzu | 4 |
| 422 | tsse | 1 |
| 423 | underclothing | 2 |
| 424 | uni/bimanual | 1 |
| 425 | uro-pathogens | 3 |
| 426 | us-results | 1 |
| 427 | vfrs.to | 1 |
| 428 | vibration/oscillation | 1 |
| 429 | video-consultation | 2 |
| 430 | video-instruction | 1 |
| 431 | videotelephony | 2 |
| 432 | vph | 2 |
| 433 | wats | 1 |
| 434 | weaners | 1 |
| 435 | wettings | 4 |
| 436 | windhoek | 2 |
| 437 | xantinuria | 1 |
| 438 | ypt1 | 1 |
| 439 | ypt2 | 1 |
| 440 | ~57 | 1 |
| 441 | £1887 | 1 |
| 442 | £8033 | 1 |
| 443 | överkalix | 2 |
| 444 | αs2-casein | 2 |
| 445 | β-d-psicofuranose | 1 |
| 446 | β-oac | 1 |
| 447 | €4451 | 2 |
| 448 | ≈350- | 1 |
| 449 | ≤0.13 | 2 |
| 450 | ≤1:4 | 1 |
| 451 | ≥2000g | 1 |
| 1 | htpr+ | 1 |
| 2 | ≈350- | 1 |
| 3 | intellectual- | 1 |
| 4 | skill- | 1 |
| 5 | subnano- | 1 |
| 6 | 1.8. | 1 |
| 7 | pcdna4.0 | 1 |
| 8 | 527.00 | 1 |
| 9 | 04/11/2010 | 1 |
| 10 | 1/1/2006-12/31/2010 | 1 |
| 11 | 182/110 | 1 |
| 12 | bcl10 | 4 |
| 13 | 13,420 | 1 |
| 14 | 10,520 | 2 |
| 15 | 1:150 | 1 |
| 16 | euro30,350 | 1 |
| 17 | nfs=0 | 1 |
| 18 | t1/t0 | 1 |
| 19 | itask-1 | 1 |
| 20 | nectins-1 | 1 |
| 21 | fhcd59-1.1 | 3 |
| 22 | 01/07/2011 | 1 |
| 23 | suwon11 | 1 |
| 24 | 5-fu/fa/cpt11 | 2 |
| 25 | radioiodine-131 | 1 |
| 26 | 3,41 | 1 |
| 27 | phe41 | 1 |
| 28 | €4451 | 2 |
| 29 | 5451 | 3 |
| 30 | 5871 | 1 |
| 31 | rs12691 | 4 |
| 32 | gdp-rac1 | 1 |
| 33 | ginsenoside-m1 | 2 |
| 34 | ypt1 | 1 |
| 35 | ifn-alpha/il-2 | 3 |
| 36 | cell1/2 | 1 |
| 37 | -2.402 | 1 |
| 38 | irkv-thchina12 | 2 |
| 39 | nsabp-b32 | 2 |
| 40 | -0.542 | 1 |
| 41 | ser72 | 1 |
| 42 | 2:1:1:1:2 | 1 |
| 43 | cs-s1-s2 | 1 |
| 44 | ypt2 | 1 |
| 45 | 16±2 | 1 |
| 46 | 22.3±6.3 | 1 |
| 47 | 23.3±7.3 | 1 |
| 48 | pnd7-13 | 1 |
| 49 | ≤0.13 | 2 |
| 50 | £8033 | 1 |
| 51 | cys263 | 2 |
| 52 | 27.37±2.73 | 1 |
| 53 | 18,593 | 1 |
| 54 | 1.2693 | 1 |
| 55 | r-ma-d3 | 1 |
| 56 | eu2o3 | 1 |
| 57 | loe-4 | 1 |
| 58 | 7.11±0.04 | 1 |
| 59 | 26,104 | 1 |
| 60 | arg904 | 1 |
| 61 | phe114 | 1 |
| 62 | 0.9624 | 1 |
| 63 | 3,244 | 1 |
| 64 | k364 | 1 |
| 65 | ≤1:4 | 1 |
| 66 | 7:7:4:4 | 1 |
| 67 | -13.05 | 1 |
| 68 | 21,935 | 1 |
| 69 | 251.55 | 1 |
| 70 | pnu-173575 | 1 |
| 71 | glu295 | 1 |
| 72 | 0.5/0.6 | 1 |
| 73 | 85,806 | 1 |
| 74 | 424,526 | 1 |
| 75 | nct01122836 | 1 |
| 76 | 15,466 | 1 |
| 77 | -€4476 | 1 |
| 78 | 80.6±22.7 | 1 |
| 79 | 23.7±5.7 | 1 |
| 80 | cell17 | 1 |
| 81 | 68.12±1.27 | 1 |
| 82 | 23.77±1.37 | 1 |
| 83 | 340+/-57 | 1 |
| 84 | -757 | 1 |
| 85 | l857 | 3 |
| 86 | ~57 | 1 |
| 87 | cys267 | 3 |
| 88 | 0.9277 | 1 |
| 89 | 8477 | 1 |
| 90 | 1986/87 | 1 |
| 91 | £1887 | 1 |
| 92 | phcn7 | 1 |
| 93 | cd208 | 1 |
| 94 | phe28 | 1 |
| 95 | st£253.38 | 1 |
| 96 | 4,398 | 1 |
| 97 | 50119 | 1 |
| 98 | ganitumab-a | 1 |
| 99 | aoxyn11a | 7 |
| 100 | moaa | 4 |
| 101 | decursin/da | 1 |
| 102 | prometra-uganda | 2 |
| 103 | microalgea | 1 |
| 104 | preterm-aga | 2 |
| 105 | andropenia | 3 |
| 106 | xantinuria | 1 |
| 107 | par-3/bazooka | 1 |
| 108 | cambrella | 2 |
| 109 | gondwana | 2 |
| 110 | routine-eus-fna | 1 |
| 111 | saccharomycotina | 1 |
| 112 | met-trna | 1 |
| 113 | fa'asamoa | 3 |
| 114 | mascara | 2 |
| 115 | photothera | 2 |
| 116 | ages-hsa | 1 |
| 117 | mhc-beta | 1 |
| 118 | craiova | 2 |
| 119 | biosimilar-infliximab | 1 |
| 120 | bevacuzimab | 1 |
| 121 | dfe/dncb | 1 |
| 122 | ebb/tblb | 1 |
| 123 | β-oac | 1 |
| 124 | cncc | 1 |
| 125 | anp-gc | 1 |
| 126 | posthyperemic | 1 |
| 127 | anticomedogenic | 1 |
| 128 | pemt-pc | 5 |
| 129 | g-mdsc | 1 |
| 130 | 3.80°c | 1 |
| 131 | 111°c | 1 |
| 132 | 7.37°c | 1 |
| 133 | 1083d | 1 |
| 134 | 1,3,7,8-tcdd | 1 |
| 135 | leukaemia-induced | 1 |
| 136 | ability/desire/need | 3 |
| 137 | gold-etched | 1 |
| 138 | resource-defined | 1 |
| 139 | gold-sputtered | 1 |
| 140 | anaemiarelated | 1 |
| 141 | tourniquet-assisted | 1 |
| 142 | diphtheria/pertussis/typhoid | 1 |
| 143 | na-and | 1 |
| 144 | dilatrend | 4 |
| 145 | cpod | 1 |
| 146 | cm-pd | 2 |
| 147 | ontd/vwd | 3 |
| 148 | 'face | 1 |
| 149 | evidence-based-practice | 1 |
| 150 | baseline-dependence | 1 |
| 151 | reverence | 1 |
| 152 | neuroblockade | 2 |
| 153 | nbd-ceramide | 1 |
| 154 | 2-substituted-3-sulfonylaminobenzamide | 2 |
| 155 | metformin+liraglutide | 1 |
| 156 | trustee | 1 |
| 157 | thermodamage | 1 |
| 158 | 3'-indolyl-3-oxindole | 2 |
| 159 | 3-methylcarbazole | 1 |
| 160 | metronidazole-clotrimazole | 1 |
| 161 | idio-fluorochrome | 1 |
| 162 | phytane | 1 |
| 163 | 3,5,3',4'-tetrahydroxy-trans-stilbene | 1 |
| 164 | 2,3-monoepoxysqualene | 1 |
| 165 | norborene | 1 |
| 166 | cis-cyclooctene | 2 |
| 167 | allyloxybenzene | 1 |
| 168 | dibucaine | 3 |
| 169 | paclitaxel/cisplatin/gemcitabine | 1 |
| 170 | thiocolchicine | 2 |
| 171 | galantamine/cdp-choline | 2 |
| 172 | 4-pentyn-1-amine | 1 |
| 173 | peptidyl-arginine | 1 |
| 174 | trijodthyronine | 1 |
| 175 | 8-thioguanosine | 4 |
| 176 | 2-hydroxy-3,4,6-trimethoxyacetophenone | 2 |
| 177 | 3,3-diethoxypropyne | 1 |
| 178 | combinedexposure | 1 |
| 179 | ips/se | 2 |
| 180 | binding/release | 1 |
| 181 | flavorase | 3 |
| 182 | stage-wise | 1 |
| 183 | paraultunense | 1 |
| 184 | ourense | 1 |
| 185 | intermediate-to-low-dose | 1 |
| 186 | β-d-psicofuranose | 1 |
| 187 | tsse | 1 |
| 188 | phosphatidylinositol-4,5-diphosphate | 1 |
| 189 | 4-hydroxymandelate | 1 |
| 190 | octyl-2-cyanoacrylate | 1 |
| 191 | isoamyl-3-oxobutanoate | 1 |
| 192 | gbs.moderate | 1 |
| 193 | 2-ketobutyrate | 7 |
| 194 | prehnite-pumpellyite | 1 |
| 195 | life.five | 1 |
| 196 | erythrocytes.we | 1 |
| 197 | biharwe | 1 |
| 198 | met-trnaf | 2 |
| 199 | caif/iaif | 1 |
| 200 | rr-lf | 1 |
| 201 | ≥2000g | 1 |
| 202 | 10-20mmhg | 2 |
| 203 | 10g/kg | 3 |
| 204 | rescrubbing | 1 |
| 205 | backbonding | 2 |
| 206 | lupus.according | 1 |
| 207 | 'preaching | 1 |
| 208 | face-washing | 1 |
| 209 | underclothing | 2 |
| 210 | evidence-gathering | 2 |
| 211 | conspiring | 1 |
| 212 | missorting | 1 |
| 213 | 'starving | 1 |
| 214 | ricin-neutralizing | 1 |
| 215 | disease-phenotype-gene-drug | 1 |
| 216 | ticl4/et3sih | 1 |
| 217 | cjph | 1 |
| 218 | vph | 2 |
| 219 | cheesecloth | 3 |
| 220 | sski | 2 |
| 221 | speen-qi | 1 |
| 222 | sert-r152e/e615k | 1 |
| 223 | 2mg/week | 1 |
| 224 | windhoek | 2 |
| 225 | sub-task | 2 |
| 226 | psycho-existential | 2 |
| 227 | taural | 2 |
| 228 | uni/bimanual | 1 |
| 229 | phbhhx/pcl | 4 |
| 230 | septum-to-free-wall | 1 |
| 231 | archaeol | 2 |
| 232 | 3,6-dioxa-1,8-octanedithiol | 2 |
| 233 | 63±11mmol/mol | 1 |
| 234 | monophenol | 1 |
| 235 | 3-cyclopentenol | 2 |
| 236 | 3h-glycerol | 2 |
| 237 | tothe.control | 1 |
| 238 | bmscs/control | 1 |
| 239 | homoeriodictyol | 4 |
| 240 | phanerogam | 1 |
| 241 | post-fdacm | 5 |
| 242 | them | 14,751 |
| 243 | him | 182 |
| 244 | 410-495nm | 1 |
| 245 | fuel-n | 1 |
| 246 | lacan | 1 |
| 247 | european/american | 1 |
| 248 | 1,3-β-dglucan | 2 |
| 249 | hongdan | 1 |
| 250 | andantiandrogen | 1 |
| 251 | god-given | 1 |
| 252 | cross-examination-given | 1 |
| 253 | 2'7'-dichlorofluorescin | 1 |
| 254 | αs2-casein | 2 |
| 255 | sitagliplin | 1 |
| 256 | 54min | 1 |
| 257 | nucleoplasmin | 1 |
| 258 | n-albumin | 1 |
| 259 | endotoxinin | 1 |
| 260 | resmethrin | 5 |
| 261 | predentin | 1 |
| 262 | laropiprant+digoxin | 1 |
| 263 | basion | 1 |
| 264 | self-persuasion | 2 |
| 265 | post-irrigation | 1 |
| 266 | vibration/oscillation | 1 |
| 267 | self-isolation | 2 |
| 268 | bromo-amination | 1 |
| 269 | photogermination | 2 |
| 270 | cooperaration | 1 |
| 271 | video-consultation | 2 |
| 272 | re-presentation | 6 |
| 273 | transquilization | 1 |
| 274 | emmetropization | 3 |
| 275 | self-stigmatization | 4 |
| 276 | immunity/infection | 1 |
| 277 | bio-detection | 2 |
| 278 | cni-reduction | 1 |
| 279 | video-instruction | 1 |
| 280 | hypercompetition | 1 |
| 281 | rix4414/placebo | 4 |
| 282 | chimaltenango | 2 |
| 283 | oyashio | 1 |
| 284 | cascadeflo | 1 |
| 285 | fistulas-in-ano | 6 |
| 286 | piero | 1 |
| 287 | vfrs.to | 1 |
| 288 | 9a-p | 1 |
| 289 | tecp | 7 |
| 290 | 33p-2mes-adp | 1 |
| 291 | lectureship | 1 |
| 292 | a.h.c.p.r | 2 |
| 293 | nmolar | 1 |
| 294 | high-reynolds-number | 1 |
| 295 | him/her | 18 |
| 296 | metallopolymer | 2 |
| 297 | them.however | 1 |
| 298 | inhibitor/activator | 1 |
| 299 | rictor | 5 |
| 300 | 100°c/s | 1 |
| 301 | 3-fluoro-2-methyldecanoyl-coas | 1 |
| 302 | ace/ras | 1 |
| 303 | adult-asthmatics | 2 |
| 304 | dermocosmetics | 2 |
| 305 | eubiotics | 1 |
| 306 | bioplastics | 5 |
| 307 | fondaparinucs | 1 |
| 308 | ask1leads | 1 |
| 309 | rdds | 1 |
| 310 | adrenocorticoids | 1 |
| 311 | biohybrids | 1 |
| 312 | 5-14-year-olds | 1 |
| 313 | 5-17-year-olds | 2 |
| 314 | 18-49-year-olds | 2 |
| 315 | 60-69-year-olds | 1 |
| 316 | half-faces | 1 |
| 317 | nonabdes | 1 |
| 318 | copepodamides | 2 |
| 319 | laminarioligosaccharides | 2 |
| 320 | selenoglycosides | 1 |
| 321 | meso-epoxides | 1 |
| 322 | operatingmodes | 1 |
| 323 | pyrrole-3-carboxaldehydes | 1 |
| 324 | c3-7α-fes | 1 |
| 325 | referrals/linkages | 1 |
| 326 | powered-toothbrushes | 1 |
| 327 | results.studies | 1 |
| 328 | individuals/families | 3 |
| 329 | micropremies | 1 |
| 330 | aromatherapies | 1 |
| 331 | gamebikes | 1 |
| 332 | age-eligibles | 2 |
| 333 | 3-diazooxindoles | 6 |
| 334 | side-holes | 1 |
| 335 | o-ethynylanisoles | 1 |
| 336 | aminoazoles | 1 |
| 337 | alkyl-tricarbastannatranes | 1 |
| 338 | methylaliphatogenes | 1 |
| 339 | n-hydroxyaminopropenes | 1 |
| 340 | polybromoarenes | 1 |
| 341 | 2-aminopyrimidines | 2 |
| 342 | 2',3',5'-tri-o-acyluridines | 2 |
| 343 | glycosyloxadiazolinethiones | 1 |
| 344 | dypnones | 2 |
| 345 | drones | 7 |
| 346 | n-alkenylnitrones | 1 |
| 347 | non-immunes | 1 |
| 348 | 3-en-1-ynes | 2 |
| 349 | arterioscleroses | 1 |
| 350 | seagrasses | 13 |
| 351 | trans-3-haloacrylates | 1 |
| 352 | allenoates | 4 |
| 353 | polyhydroxyalkanaotes | 1 |
| 354 | preoligodendrocytes | 2 |
| 355 | aris.objectives | 1 |
| 356 | treatment.objectives | 1 |
| 357 | mini-helixes | 1 |
| 358 | ln-mofs | 1 |
| 359 | wettings | 4 |
| 360 | 4-6months | 2 |
| 361 | brevipalpis | 1 |
| 362 | csf/leukoaraiosis | 1 |
| 363 | nephrohydrosis | 1 |
| 364 | perimyocarditis | 2 |
| 365 | stockings/socks | 1 |
| 366 | co-medicals | 1 |
| 367 | antisocials | 1 |
| 368 | cattails | 8 |
| 369 | topsoils | 3 |
| 370 | aflfff-malls | 2 |
| 371 | thp-1cells | 2 |
| 372 | pnls | 11 |
| 373 | bromophenols | 3 |
| 374 | tisis/icp-ms | 1 |
| 375 | non-beta-lactams | 4 |
| 376 | errors/problems | 3 |
| 377 | multi-algorithms | 1 |
| 378 | 24-atoms | 1 |
| 379 | aryllithiums | 2 |
| 380 | 60-ns | 1 |
| 381 | aggregans | 1 |
| 382 | target-organs | 2 |
| 383 | indo-trinidadians | 1 |
| 384 | lithuanians | 1 |
| 385 | olympians | 1 |
| 386 | eumetazoans | 1 |
| 387 | bedpans | 5 |
| 388 | 3-formylfurans | 2 |
| 389 | promutagens | 2 |
| 390 | uro-pathogens | 3 |
| 391 | polysulfoanions | 1 |
| 392 | microdecisions | 1 |
| 393 | readmissions/admissions | 1 |
| 394 | epros | 1 |
| 395 | cserps | 5 |
| 396 | salamanders | 6 |
| 397 | non-bingers | 3 |
| 398 | governments/policymakers | 1 |
| 399 | sicklers | 1 |
| 400 | weaners | 1 |
| 401 | physician-learners | 1 |
| 402 | beach-goers | 1 |
| 403 | truck-drivers | 3 |
| 404 | inotropes/vasopressors | 2 |
| 405 | m1-receptors | 1 |
| 406 | isoreceptors | 3 |
| 407 | 6yrs | 1 |
| 408 | change/readiness | 1 |
| 409 | photo-oxidative-stress | 1 |
| 410 | wats | 1 |
| 411 | noncontacts | 2 |
| 412 | anti-lts | 2 |
| 413 | us-results | 1 |
| 414 | chelants | 2 |
| 415 | matriculants | 3 |
| 416 | demulcents | 1 |
| 417 | non-adolescents | 4 |
| 418 | rehab-patients | 1 |
| 419 | controls/designs/patients | 1 |
| 420 | embryologists | 9 |
| 421 | integrationists | 2 |
| 422 | clinician-scientists | 5 |
| 423 | parnuts | 1 |
| 424 | sylvius | 8 |
| 425 | letrozole/temsirolimus | 2 |
| 426 | bpvs | 6 |
| 427 | sipvs | 3 |
| 428 | afl/at | 2 |
| 429 | 8-ohdpat | 2 |
| 430 | lodgment | 2 |
| 431 | radio-content | 2 |
| 432 | solutions-but | 1 |
| 433 | tso-yueh-tzu | 4 |
| 434 | 161.2μv | 1 |
| 435 | överkalix | 2 |
| 436 | dcj/day | 2 |
| 437 | multi-pharmacy | 3 |
| 438 | hemorrhagy | 1 |
| 439 | pediatric-gastroenterology | 3 |
| 440 | lithostatically | 1 |
| 441 | prospectically | 1 |
| 442 | videotelephony | 2 |
| 443 | dc-therapy | 1 |
| 444 | antibioticotherapy | 1 |
| 445 | granulomorphometry | 2 |
| 446 | psaty | 2 |
| 447 | mutagencity | 1 |
| 448 | elastoviscosity | 1 |
| 449 | 11α-hydroxy | 1 |
| 450 | 27°-30° | 1 |
| 451 | -30.9° | 1 |